Additionally, our immunohistochemical (IHC) analysis revealed distinct expression patterns of mutant KRT32 of PRP patients compared to that in healthy controls and PRP patients without KRT32 mutations (Supplementary Fig. 1D). The gene discussed is KRT32; the disease is familial pityriasis rubra pilaris.